US 12,402,832 B2
Autonomous drug delivery system
Jerome J. Novak, Jr., Lake Forest, CA (US)
Assigned to Masimo Corporation, Irvine, CA (US)
Filed by MASIMO CORPORATION, Irvine, CA (US)
Filed on Dec. 18, 2023, as Appl. No. 18/543,932.
Application 17/581,028 is a division of application No. 15/909,359, filed on Mar. 1, 2018, granted, now 11,259,745, issued on Mar. 1, 2022.
Application 18/543,932 is a continuation of application No. 17/581,028, filed on Jan. 21, 2022, granted, now 11,883,190.
Application 15/909,359 is a continuation in part of application No. 14/608,188, filed on Jan. 28, 2015, granted, now 10,086,138, issued on Oct. 2, 2018.
Claims priority of provisional application 61/932,437, filed on Jan. 28, 2014.
Prior Publication US 2024/0138760 A1, May 2, 2024
Int. Cl. A61B 5/00 (2006.01); A61B 5/021 (2006.01); A61B 5/318 (2021.01); A61M 5/14 (2006.01); A61M 5/142 (2006.01); A61M 5/168 (2006.01); A61M 5/172 (2006.01); G16H 20/17 (2018.01); G16H 40/20 (2018.01); G16H 40/63 (2018.01); G16H 40/67 (2018.01); G16H 50/20 (2018.01); G16H 50/50 (2018.01)
CPC A61B 5/4839 (2013.01) [A61B 5/021 (2013.01); A61B 5/746 (2013.01); A61M 5/14 (2013.01); A61M 5/142 (2013.01); A61M 5/168 (2013.01); A61M 5/1723 (2013.01); G16H 20/17 (2018.01); G16H 40/20 (2018.01); G16H 40/63 (2018.01); G16H 40/67 (2018.01); G16H 50/20 (2018.01); G16H 50/50 (2018.01); A61B 5/0015 (2013.01); A61B 5/318 (2021.01); A61M 2005/1405 (2013.01); A61M 2205/18 (2013.01); A61M 2205/3303 (2013.01); A61M 2205/3507 (2013.01); A61M 2205/3553 (2013.01); A61M 2205/3561 (2013.01); A61M 2205/3569 (2013.01); A61M 2205/3584 (2013.01); A61M 2205/3592 (2013.01); A61M 2205/50 (2013.01); A61M 2205/502 (2013.01); A61M 2205/581 (2013.01)] 20 Claims
OG exemplary drawing
 
1. An automated first responder system, the system comprising:
a patient monitor comprising a hardware processor configured to derive physiological parameter values from physiological signals obtained from one or more physiological sensors coupled with a patient;
a gateway device, the patient monitor in communication with the gateway device over a network, wherein the gateway device is in communication with at least one clinician device and an electronic medical record (EMR) database storing patient data, the patient data comprising lab results of the patient, wherein the patient monitor is configured to access the patient data stored in the EMR database through the gateway device; and
an autonomous delivery device in communication with the patient monitor, the autonomous delivery device comprising a substance;
wherein the hardware processor of the patient monitor is configured to:
analyze the physiological parameter values and the patient data based on a diagnostic model;
determine that the physiological parameter values and the patient data correspond with the diagnostic model;
in response to determining that it is a first time the physiological parameter values and the patient data correspond with the diagnostic model, initiate a treatment workflow specific to the diagnostic model, the treatment workflow includes instructing the autonomous delivery device to automatically administer a first dose of the substance to the patient;
in response to determining that it is not the first time the physiological parameter values and the patient data correspond with the diagnostic model, output an alert to the at least one clinician device so that a clinician can decide whether to administer a second dose of the substance to the patient, the second dose being greater than the first dose.